Fennec Pharmaceuticals
FENC
FENC
43 hedge funds and large institutions have $120M invested in Fennec Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% more funds holding
Funds holding: 31 → 43 (+12)
30% more capital invested
Capital invested by funds: $92.1M → $120M (+$27.5M)
3.81% more ownership
Funds ownership: 43.6% → 47.42% (+3.8%)
Holders
43
Holding in Top 10
3
Calls
$3.09M
Puts
$233K
Top Buyers
| 1 | +$2.61M | |
| 2 | +$1.47M | |
| 3 | +$1.22M | |
| 4 |
SCM
Solas Capital Management
Darien,
Connecticut
|
+$1.16M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.03M |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$814K | |
| 3 | -$324K | |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
-$202K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$121K |